The FDA has approved Benlysta in an autoinjector that can be used at home to treat lupus nephritis, a kidney complication, in children.

Columnist Candace Semien plunges into the debate of whether to use disabled, differently abled, or another term to describe a ...

Pain wakes me at 3:18 a.m., reminding me that lupus stopped me from working. “Yeah, I know,” I sleep-whisper and stare at the digital clock until box breathing cools me back to sleep. An hour later, 4 ...

Lupus News Today is a digital platform intended to provide the lupus community with the most recent news and information, as well as first-hand community perspectives from our patient and caregiver ...

Seattle Children's will start a clinical trial testing CAR T-cell therapy in children with lupus this summer after getting FDA clearance.

Read about a Turkish study showing that anemia and lower levels of lymphocytes are the most common blood-related disorders in systemic lupus erythematosus.

A recent study of three groups of patients with systemic lupus erythematosus (SLE) has, for the first time, identified a link between iron deficiency and fatigue.

A pivotal Phase 2 trial found that adding RC18, by RemeGen, to standard SLE therapy significantly lessen disease activity and was well-tolerated.

Telitacicept, a B-cell-targeting therapy developed by RemeGen, outperformed a placebo at reducing the severity of systemic lupus erythematosus (SLE) in a Phase 3 clinical trial in China, the company ...

The study will evaluate the safety, pharmacological properties, and efficacy of the CAR NK-cell therapy in people with moderate to severe SLE.

Kyverna Therapeutics plans to initiate a Phase 1 trial of KYV-101, a potential lupus nephritis treatment, in early 2023.

A recent beach adventure prompts columnist Candace Semien to reflect on the value of doing something for the first time.